- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Metropolis Healthcare has approved the acquisition of a 100% stake in Core Diagnostics Private Limited for a total consideration of INR 246.83 crore, to be funded through a combination of cash and a preferential issue of equity shares, pending shareholder approval. This acquisition aims to bolster Metropolis's cancer testing capabilities and enhance its market presence in Northern and Eastern India by leveraging Core Diagnostics' established relationships with key healthcare providers. Core Diagnostics has a net worth of INR 22.03 crore and a turnover of INR 110.32 crore for FY 23-24. The transaction is expected to close within 60 days following the signing of definitive agreements, with the cash component being INR 135.76 crore and the share swap amounting to up to INR 111.07 crore. This strategic move puts Metropolis in a favorable position to expand its service offerings and operational efficiency within the diagnostics sector.